We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPL icon
1201
Solitario Resources
XPL
$68.9M
$117K ﹤0.01%
205,000
– –
ORKA
1202
Oruka Therapeutics
ORKA
$5.94B
$117K ﹤0.01%
3,912
+2,083
+114% +$58.9K
ZDGE icon
1203
Zedge
ZDGE
$40.5M
$116K ﹤0.01%
40,380
– –
TISI icon
1204
Team
TISI
$77.8M
$114K ﹤0.01%
15,380
-11,510
-43% -$159K
DYN icon
1205
Dyne Therapeutics
DYN
$4.83B
$113K ﹤0.01%
+16,400
New +$113K
FBRX icon
1206
Forte Biosciences
FBRX
$1.57B
$113K ﹤0.01%
3,475
– –
TERN
1207
DELISTED
Terns Pharmaceuticals
TERN
$113K ﹤0.01%
45,500
-17,200
-27% -$34.4K
ENSV
1208
DELISTED
Enservco Corp.
ENSV
$110K ﹤0.01%
56,093
– –
CRVO icon
1209
CervoMed
CRVO
$25.6M
$109K ﹤0.01%
+11,043
New +$137K
MIND icon
1210
MIND Technology
MIND
$46.7M
$109K ﹤0.01%
12,332
– –
AKUS
1211
DELISTED
Akouos Inc
AKUS
$109K ﹤0.01%
+23,241
New +$82.1K
UBX
1212
DELISTED
Unity Biotechnology
UBX
$108K ﹤0.01%
19,145
-4,500
-19% -$37.5K
MTEM
1213
DELISTED
Molecular Templates, Inc.
MTEM
$108K ﹤0.01%
7,913
– –
LABP
1214
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$108K ﹤0.01%
14,900
-1,000
-6% -$9.1K
ONCR
1215
DELISTED
Oncorus, Inc.
ONCR
$105K ﹤0.01%
83,300
-35,000
-30% -$47.5K
SPRB
1216
Spruce Biosciences
SPRB
$128M
$104K ﹤0.01%
800
-2,484
-76% -$318K
HARP
1217
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$104K ﹤0.01%
5,440
-4,186
-43% -$108K
STRR
1218
DELISTED
Star Equity Holdings
STRR
$103K ﹤0.01%
22,078
-3,000
-12% -$14.4K
BIOC
1219
DELISTED
Biocept, Inc.
BIOC
$103K ﹤0.01%
3,648
+518
+17% +$23.6K
AMPE
1220
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$102K ﹤0.01%
2,023
– –
RCOR
1221
DELISTED
Renovacor, Inc.
RCOR
$101K ﹤0.01%
+49,900
New +$132K
OCC icon
1222
Optical Cable Corp
OCC
$138M
$100K ﹤0.01%
27,600
– –
ALIM
1223
DELISTED
Alimera Sciences
ALIM
$100K ﹤0.01%
18,300
– –
LCI
1224
DELISTED
Lannett Company, Inc.
LCI
$100K ﹤0.01%
43,300
-11,375
-21% -$28.3K
MRIN
1225
DELISTED
Marin Software
MRIN
$99K ﹤0.01%
10,000
– –
47 48
49
50 51

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.